582
Participants
Start Date
July 16, 2008
Primary Completion Date
February 19, 2010
Study Completion Date
February 19, 2010
Albaconazole 100mg
Albaconazole for 36 weeks
Albaconazole 200mg
Albaconazole for 36 weeks
Albaconazole 400mg
Albaconazole for 36 weeks
Albaconazole 400mg
Albaconazole for 24 weeks, Placebo for 12 weeks
Placebo 400 mg
Placebo for 36 weeks
Dermatology Centre, University of Iceland, Hudlaeknaslodin
NYU Medical Center, New York
Education and Research Foundation, Lynchburg
University of North Carolina at Chapel Hill, Chapel Hill
Gwinnett Clinical Research Center, Inc., Snellville
MedaPhase, Inc, Newnan
Greater Miami Skin & Laser Center, Miami Beach
International Dermatology Research Inc, Miami
Miami Dermatology Research Institute LLC, North Miami Beach
University of Alabama at Birmingham, Birmingham
Tennessee Clinical Research, Nashville
The Skin Wellness Center, Knoxville
Welborn Clinic, Evansville
Henry Ford Medical Center, Detroit
Minnesota Clinical Study Center, Fridley
Skin Specialists, Inc, Omaha
Research Across America, Dallas
Center for Clinical Studies, Houston
J & S Studies, Inc., College Station
DermResearch, Inc., Austin
Thomas J. Stephens & Associates, Inc. Colorado Research Center, Colorado Springs
DermatologyResearch Center, Salt Lake City
Genova Clinical Research, Tucson
Impact Clinical Trials, Beverly Hills
Therapeutics Clinical Research, San Diego
UCSF Dermatology Research, San Francisco
Center for Dermatology Clinical Research, Fremont
Northern California Research, Carmichael
Oregon Dermatology & Research Centre, Portland
Oregon Medical, Portland
Ultranova Skincare, Barrie
North Bay Dermatology Centre Inc., North Bay
K. Papp Clinical Research Inc., Waterloo
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Stiefel, a GSK Company
INDUSTRY